Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
14.73
+0.40 (2.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
Medifast Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 2.09 | 99.42 | 143.57 | 164.03 | 102.86 | Upgrade
|
| Depreciation & Amortization | 3.52 | 13.11 | 10.98 | 6.81 | 4.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.09 | 1.17 | 2.13 | 0 | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 9.19 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.2 | -0.32 | 0.01 | 0.09 | 0.32 | Upgrade
|
| Stock-Based Compensation | 7.36 | 8.19 | 11.05 | 9.9 | 6.8 | Upgrade
|
| Other Operating Activities | 8.78 | 5.82 | 5.17 | 1.35 | 3.79 | Upgrade
|
| Change in Inventory | 12.17 | 64.27 | 61.19 | -126.65 | -4.62 | Upgrade
|
| Change in Accounts Payable | -34.99 | -35.71 | -37.59 | 54.38 | 28.01 | Upgrade
|
| Change in Income Taxes | 10.21 | -9.16 | 1.37 | -0.95 | 5.17 | Upgrade
|
| Change in Other Net Operating Assets | 2.87 | 0.87 | -3.32 | -14.43 | -1.66 | Upgrade
|
| Operating Cash Flow | 24.48 | 147.66 | 194.57 | 94.55 | 145.2 | Upgrade
|
| Operating Cash Flow Growth | -83.42% | -24.11% | 105.80% | -34.88% | 72.32% | Upgrade
|
| Capital Expenditures | -7.45 | -6.48 | -16.68 | -34.21 | -5.89 | Upgrade
|
| Investment in Securities | -19.07 | -54.56 | 5.27 | 5.15 | 4.61 | Upgrade
|
| Investing Cash Flow | -26.52 | -61.05 | -11.41 | -29.06 | -1.28 | Upgrade
|
| Issuance of Common Stock | 0.04 | 0.19 | - | 0.81 | 1.6 | Upgrade
|
| Repurchase of Common Stock | -0.84 | -6.96 | -127.96 | -62.09 | -5.55 | Upgrade
|
| Common Dividends Paid | -0.72 | -73.02 | -71.62 | -63.86 | -53.19 | Upgrade
|
| Financing Cash Flow | -1.52 | -79.79 | -199.58 | -125.13 | -57.14 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0.07 | -0.07 | 0.11 | -0.02 | Upgrade
|
| Net Cash Flow | -3.51 | 6.75 | -16.49 | -59.54 | 86.75 | Upgrade
|
| Free Cash Flow | 17.02 | 141.17 | 177.89 | 60.34 | 139.31 | Upgrade
|
| Free Cash Flow Growth | -87.94% | -20.64% | 194.83% | -56.69% | 87.74% | Upgrade
|
| Free Cash Flow Margin | 2.83% | 13.17% | 11.13% | 3.95% | 14.90% | Upgrade
|
| Free Cash Flow Per Share | 1.55 | 12.93 | 15.78 | 5.11 | 11.76 | Upgrade
|
| Cash Income Tax Paid | -1.62 | 34.26 | 37.21 | 56.76 | 24.64 | Upgrade
|
| Levered Free Cash Flow | 6.53 | 106.22 | 154.46 | 35.66 | 122.17 | Upgrade
|
| Unlevered Free Cash Flow | 6.53 | 106.22 | 154.89 | 35.81 | 122.17 | Upgrade
|
| Change in Net Working Capital | 6.51 | -12.4 | -34.04 | 81.85 | -33.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.